American boxer Ryan Garcia’s stunning victory over Devin Haney last month has been marred by allegations of doping. ESPN reported that Garcia tested positive for the banned substance Ostarine on the day before and the morning of the April 20 bout. The report also suggests that Garcia may have tested positive for another banned substance, 19-norandrosterone, although this result is unconfirmed.
Ostarine is a performance-enhancing drug used to prevent muscle loss and improve lean body mass. It is commonly used in the treatment of women with breast cancer. Garcia’s positive test results have raised questions about the legitimacy of his victory over Haney, who retained his WBC super-lightweight title.
Garcia has vehemently denied any wrongdoing, claiming that the allegations are “fake news.” He has suggested that a tainted herbal supplement may be responsible for the positive test result. However, the Voluntary Anti-Doping Association (VADA), which oversees drug-testing in boxing and mixed martial arts, has confirmed the authenticity of the test results.
The allegations against Garcia have sent shockwaves through the boxing world. If proven true, they could result in Garcia facing a lengthy suspension and potentially losing his victory over Haney. The incident has also raised concerns about the prevalence of doping in boxing and the need for stricter drug-testing measures.
Garcia’s case is a reminder that even the most talented athletes are not immune to the temptation of using performance-enhancing drugs. It is essential for boxing authorities to continue to crack down on doping and ensure that the sport remains fair and competitive.
